Insights

Loading spinner
Gathering insights about DayaMed

DayaMed Tech Stack

DayaMed uses 8 technology products and services including WP Rocket, Unpkg, WordPress, and more. Explore DayaMed's tech stack below.

  • WP Rocket
    Caching
  • Unpkg
    Content Delivery Network
  • WordPress
    Content Management System
  • MySQL
    Database
  • Twemoji
    Font Scripts
  • JSON-LD
    Javascript Frameworks
  • Swiper
    Javascript Libraries
  • PHP
    Programming Languages

Media & News

DayaMed's Email Address Formats

DayaMed uses at least 1 format(s):
DayaMed Email FormatsExamplePercentage
Last@dayamed.comDoe@dayamed.com
86%
LF@dayamed.comDJ@dayamed.com
5%
FLast@dayamed.comJDoe@dayamed.com
4%
FL@dayamed.comJD@dayamed.com
5%

Frequently Asked Questions

Where is DayaMed's headquarters located?

Minus sign iconPlus sign icon
DayaMed's main headquarters is located at 1 East Liberty Street, Suite 600. The company has employees across 1 continents, including North America.

What is DayaMed's official website and social media links?

Minus sign iconPlus sign icon
DayaMed's official website is dayamed.com and has social profiles on LinkedInCrunchbase.

What is DayaMed's SIC code NAICS code?

Minus sign iconPlus sign icon
DayaMed's SIC code is 2835 - In Vitro and In Vivo Diagnostic Substances NAICS code is 92 - Public Administration.

How many employees does DayaMed have currently?

Minus sign iconPlus sign icon
As of December 2025, DayaMed has approximately 51 employees across 1 continents, including North America. Key team members include Chief Strategy Officer, Population Health: L. S.Chief Product Officer (advisor): B. H.Chief Nursing Officer: D. K.. Explore DayaMed's employee directory with LeadIQ.

What industry does DayaMed belong to?

Minus sign iconPlus sign icon
DayaMed operates in the Government Administration industry.

What technology does DayaMed use?

Minus sign iconPlus sign icon
DayaMed's tech stack includes WP RocketUnpkgWordPressMySQLTwemojiJSON-LDSwiperPHP.

What is DayaMed's email format?

Minus sign iconPlus sign icon
DayaMed's email format typically follows the pattern of Last@dayamed.com. Find more DayaMed email formats with LeadIQ.

How much funding has DayaMed raised to date?

Minus sign iconPlus sign icon
As of December 2025, DayaMed has raised $500K in funding. The last funding round occurred on Mar 29, 2024 for $500K.

When was DayaMed founded?

Minus sign iconPlus sign icon
DayaMed was founded in 2017.

DayaMed

Government AdministrationNevada, United States51-200 Employees

DayaMed is a population health company focused on medication adherence and disease management. We utilize our clinical services team and artificial intelligence combined with multiple real-time sensors & engagement devices to improve patient clinical outcomes, reduce healthcare costs, and improve the patient experience.  Our US HQ is proudly located along the Eastern Sierras in Reno, Nevada with our global HQ in Waterloo, Ontario, Canada.

DayaMed provides our services to pharmacies, hospitals, health insurance companies, pharmaceutical companies, governments, PBMs, and employers globally.

Section iconCompany Overview

Headquarters
1 East Liberty Street, Suite 600
SIC Code
2835 - In Vitro and In Vivo Diagnostic Substances
NAICS Code
92 - Public Administration
Founded
2017
Employees
51-200

Section iconMedia & News

Section iconFunding & Financials

  • $500K

    DayaMed has raised a total of $500K of funding over 3 rounds. Their latest funding round was raised on Mar 29, 2024 in the amount of $500K.

  • $1M$10M

    DayaMed's revenue is estimated to be in the range of $1M$10M

Section iconFunding & Financials

  • $500K

    DayaMed has raised a total of $500K of funding over 3 rounds. Their latest funding round was raised on Mar 29, 2024 in the amount of $500K.

  • $1M$10M

    DayaMed's revenue is estimated to be in the range of $1M$10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.